Delivery Order SPE2DB22D9239-SPE2DB25FDD70

Award Date 10/8/24
Potential Completion Date 10/30/24
Potential Value $46K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $58,744.30 firm fixed-price delivery order contract is for the supply of ADCETRIS 50 MG VIALS, a specialized pharmaceutical product. The contract has an ultimate completion date of December 15, 2021 and is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. holds a larger...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $44,728.26 firm fixed-price delivery order contract is for the supply of ADCETRIS 50 MG VIALS, a specialty oncology medication. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $40,102.08 firm fixed-price delivery order is for the supply of ADCETRIS 50 MG VIALS, with a completion date of December 1, 2022. This award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This...
This federal contract award, with ID SPE2DB22D9239 and SPE2DB25FDD97, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $61,258.56 firm fixed-price delivery order is for the supply of ADCETRIS 50 MG VIALS, a specialized oncology medication. The contract has an ultimate completion date of November 7, 2024. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite...
This federal contract award is to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract award, valued at $48,718.74, is a delivery order awarded by the Defense Logistics Agency (DLA) for the procurement of ADCETRIS 50 MG VIALS. The contract is a firm fixed-price delivery order and does not have a set-aside designation. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $40,598.90 firm fixed-price delivery order is for the supply of 4567967746 ADCETRIS 50 MG VIALS. DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC...
This is a firm fixed-price delivery order valued at $45,943.92, awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of ADCETRIS 50 MG VIALS, a specialized pharmaceutical product, to support the medical supply needs of the Department of Defense (DoD). DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $45,943.92 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4564357709 ADCETRIS 50 MG VIALS. This Delivery Order contract is part of a larger single-award Indefinite Delivery Contract (IDC) between the DLA and DMS Pharmaceutical Group valued at up to $499,999,999, which runs through December 31, 2025. The IDC...
This federal contract award, valued at $107,360.80, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order under the DLA's SPE2DB program, which is a single-award Indefinite Delivery Contract (IDC) valued at $499,999,999 and valid through November 2026. The contract is for the delivery of ADCETRIS 50 MG VIALS, a specialized pharmaceutical product....
This federal contract award is a delivery order worth $32,479.16 issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract provides for the delivery of ADCETRIS 50 MG VIALS, a specialized pharmaceutical product, with an ultimate completion date of March 11, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA...
  • SPE2DB22D9239
    Indefinite Delivery Contract
  • SPE2DB22D9239-SPE2DB25FDD70
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $45,943.92 firm fixed-price delivery order is for the provision of ADCETRIS 50 MG VIALS, a pharmaceutical product, with an ultimate completion date of October 30, 2024.

DMS Pharmaceutical Group Inc. holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. This IDC, which runs through December 31, 2025, complements the company's separate prime vendor contracts for direct distribution of prescription drugs and pharmacy services to Department of Defense (DoD) sites, solidifying its position as a crucial supplier in the federal pharmaceutical supply chain.

Generated 1/7/25, 11:42 AM